 This is On Point. I'm Deborah Becker. We're talking about post-transplant drugs this hour and what's holding up potential new medications. We're joined by Dr. Ken Newell, a transplant surgeon at Emory University Hospital. Also with us, Bill Fitzsimmons. He's an advisor to the Transplant Therapeutic Consortium. He spent 29 years in the pharmaceutical industry where he helped develop several transplant drugs. And our guests both say that the science is there to improve